Ossen Innovation Company ADR (OSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,613 | 4,136 | 4,070 | N/A | 13,050 |
| Depreciation Amortization | 1,416 | 1,531 | 1,565 | N/A | 2,000 |
| Accounts receivable | 10,516 | -5,564 | -2,466 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,318 | 2,713 | -68 | N/A | N/A |
| Other Working Capital | 4,412 | -3,862 | 4,377 | N/A | -35,310 |
| Other Operating Activity | -9,199 | 2,851 | 2,534 | 0 | 120 |
| Operating Cash Flow | $12,442 | $1,804 | $10,011 | $N/A | $-20,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -81 | 8,056 | N/A | -160 |
| Investing Cash Flow | $-30 | $-81 | $8,056 | $N/A | $-160 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 54,665 | 84,287 | 139,999 | N/A | N/A |
| Debt Issued | N/A | 15,946 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -4,581 | N/A | N/A |
| Common Stock Repurchased | -59 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -59,038 | -103,733 | -157,478 | 0 | 7,660 |
| Financing Cash Flow | $-4,431 | $-3,501 | $-22,060 | $N/A | $7,660 |
| Exchange Rate Effect | -7,853 | 1,322 | 3,136 | N/A | 1,880 |
| Beginning Cash Position | 685 | 1,140 | 1,997 | N/A | 12,320 |
| End Cash Position | 812 | 685 | 1,140 | N/A | 1,560 |
| Net Cash Flow | $128 | $-455 | $-857 | $N/A | $-10,750 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,442 | 1,804 | 10,011 | N/A | -20,140 |
| Capital Expenditure | -30 | -81 | -16 | N/A | N/A |
| Free Cash Flow | 12,412 | 1,723 | 9,995 | 0 | -20,140 |